Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Qingyuan Zhang, Pin Zhang, Min Yan [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients

Xiaomeng Jia, Kainan Wang, Xueqing Wang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Article commentary

First published 2020-9

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Jacopo Giuliani, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open access

Editorial

First published 2018

Managing advanced HR-positive,HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

Lorenzo Rossi, Amelia McCartney, Emanuela Risi [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2021

Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case

Noman Ahmed Jang Khan, Mahmoud Abdallah, Maria Tria Tirona

Journal of Investigative Medicine High Impact Case Reports

Free access

Review article

First published 2017-2

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Andrea Rocca, Alessio Schirone, Roberta Maltoni [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

Search results